The prognostic value of TP53 and tumor suppressor gene mutations in temozolomide-treated IDH1 mutant low-grade glioma

被引：0
|
作者：
Salem, Yahia E.
Abu Alragheb, Bayan O.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7361
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7361
引用
收藏
页数：2
相关论文
共 46 条
  • [21] IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy
    Yasuo Iwadate
    Tomoo Matsutani
    Seiichiro Hirono
    Shiro Ikegami
    Natsuki Shinozaki
    Naokatsu Saeki
    Journal of Neuro-Oncology, 2015, 124 : 493 - 500
  • [22] IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy
    Iwadate, Yasuo
    Matsutani, Tomoo
    Hirono, Seiichiro
    Ikegami, Shiro
    Shinozaki, Natsuki
    Saeki, Naokatsu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (03) : 493 - 500
  • [23] The Significance of IDH1 Mutations in Tumor-Associated Seizure in 60 Chinese Patients with Low-Grade Gliomas
    Liang, Ruofei
    Fan, Yingjun
    Wang, Xiang
    Mao, Qing
    Liu, Yanhui
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [24] Detection of the IDH1/2 Gene Mutations in Tumor Samples with Low-Abundance Mutant Allele
    Varachev, V. O.
    Guskov, D. A.
    Susova, O. Yu.
    Shekhtman, A. P.
    Rogozhin, D. V.
    Surzhikov, S. A.
    Chudinov, A. V.
    Zasedatelev, A. S.
    Nasedkina, T. V.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2024, 50 (05) : 2058 - 2065
  • [25] INHERITED POLYMORPHISM IN CHROMOSOME 8Q24 COOPERATES WITH MUTANT IDH1, TRP53 AND ATRX LOSS TO INDUCE LOW-GRADE GLIOMA
    Yanchus, Connor
    Drucker, Kristen
    Kollmeyer, Thomas
    Abyzov, Alexej
    Lachance, Daniel
    Eckel-Passow, Jeanette
    Mak, Tak
    Taylor, Michael
    Zadeh, Gelareh
    Dirks, Peter
    Jenkins, Robert
    Schramek, Daniel
    NEURO-ONCOLOGY, 2021, 23 : 6 - 6
  • [26] TUMOR SUPPRESSOR SYNERGY IN HIGH-GRADE GLIOMA: COMBINATORIAL MUTATIONS OF PTEN, TP53, AND RB1 GENERATE MODELS FOR HIGH-GRADE GLIOMA WITH SOMATIC MUTATIONS AND HISTOPATHOLOGY RELEVANT TO HUMAN DISEASE
    Chow, Lionel M.
    Endersby, Raelene
    Zhu, Xiaoyan
    Rankin, Sherri
    Qu, Chunxu
    Zhang, Junyuan
    Ellison, David W.
    Baker, Suzanne J.
    NEURO-ONCOLOGY, 2010, 12 : 136 - 136
  • [27] Detection of IDH1/2 and TP53 Mutations and MGMT Methylation in High Grade Gliomas of the Central Nervous System by the Next Generation Sequencing and Pyrosequencing
    Zhan, Yougen
    Sidorenko, Tatyana
    Waluszko, Aneta
    Zhang, David Y.
    Ye, Fei
    MODERN PATHOLOGY, 2017, 30 : 440A - 440A
  • [28] Detection of IDH1/2 and TP53 Mutations and MGMT Methylation in High Grade Gliomas of the Central Nervous System by the Next Generation Sequencing and Pyrosequencing
    Zhan, Yougen
    Sidorenko, Tatyana
    Waluszko, Aneta
    Zhang, David Y.
    Ye, Fei
    LABORATORY INVESTIGATION, 2017, 97 : 440A - 440A
  • [29] Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
    Tonnesen, Ea Maria Tonning
    Stougaard, Magnus
    Meldgaard, Peter
    Lade-Keller, Johanne
    JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (01) : 54 - 60
  • [30] Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis
    Phan, Kevin
    Ng, Wyatt
    Lu, Victor M.
    McDonald, Kerrie L.
    Fairhall, Jacob
    Reddy, Rajesh
    Wilson, Peter
    WORLD NEUROSURGERY, 2018, 111 : E539 - E545
12345